In the past week, OCGN stock has gone up by 22.39%, with a monthly gain of 74.26% and a quarterly surge of 203.70%. The volatility ratio for the week is 20.31%, and the volatility levels for the last 30 days are 13.29% for Ocugen Inc The simple moving average for the last 20 days is 40.99% for OCGN’s stock, with a simple moving average of 189.86% for the last 200 days.
Is It Worth Investing in Ocugen Inc (NASDAQ: OCGN) Right Now?
The 36-month beta value for OCGN is also noteworthy at 3.54. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for OCGN is 250.87M, and at present, short sellers hold a 14.11% of that float. The average trading volume of OCGN on April 01, 2024 was 7.75M shares.
OCGN) stock’s latest price update
The stock price of Ocugen Inc (NASDAQ: OCGN) has dropped by -7.87 compared to previous close of 1.78. Despite this, the company has seen a gain of 22.39% in its stock price over the last five trading days. InvestorPlace reported 2024-03-25 that Ocugen (NASDAQ: OCGN ) stock is up on Monday as investors celebrate an update on class action lawsuit that the clinical-stage biopharmaceutical company was facing. This lawsuit came from investors who believe the company misled them.
Analysts’ Opinion of OCGN
Many brokerage firms have already submitted their reports for OCGN stocks, with Chardan Capital Markets repeating the rating for OCGN by listing it as a “Buy.” The predicted price for OCGN in the upcoming period, according to Chardan Capital Markets is $3.50 based on the research report published on March 01, 2023 of the previous year 2023.
Mizuho, on the other hand, stated in their research note that they expect to see OCGN reach a price target of $5. The rating they have provided for OCGN stocks is “Buy” according to the report published on August 23rd, 2022.
ROTH Capital gave a rating of “Buy” to OCGN, setting the target price at $8 in the report published on June 15th of the previous year.
OCGN Trading at 89.84% from the 50-Day Moving Average
After a stumble in the market that brought OCGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.09% of loss for the given period.
Volatility was left at 13.29%, however, over the last 30 days, the volatility rate increased by 20.31%, as shares surge +75.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +215.38% upper at present.
During the last 5 trading sessions, OCGN rose by +22.39%, which changed the moving average for the period of 200-days by +257.38% in comparison to the 20-day moving average, which settled at $1.1984. In addition, Ocugen Inc saw 185.22% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OCGN starting from Zhang Junge, who purchase 200,278 shares at the price of $0.50 back on Jun 14 ’23. After this action, Zhang Junge now owns 1,077,182 shares of Ocugen Inc, valued at $99,999 using the latest closing price.
Stock Fundamentals for OCGN
The total capital return value is set at -1.28. Equity return is now at value -98.28, with -79.11 for asset returns.
Based on Ocugen Inc (OCGN), the company’s capital structure generated 0.1 points at debt to capital in total, while cash flow to debt ratio is standing at -10.45. The debt to equity ratio resting at 0.11. The interest coverage ratio of the stock is 23.4.
Currently, EBITDA for the company is -84.87 million with net debt to EBITDA at 0.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.08.
Conclusion
In summary, Ocugen Inc (OCGN) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
